he threw the lobbyists out and a reporter asked why and he said " he found big pharma no different than the taliban i thought. second example, sarah chase, a former reporter who writes about corruption around the world. 2015, she wrote a book about ofruption titled "thieves state, why corruption threatens global security." argues the violent religious extremism is related to government corruption, not religious ideology. it came out in 2015. ae says she did not expect version of an extreme reaction so quickly in the united states. that is what we got. she says much of the phot for bernie sanders and trump was one of these wrecking balls anticorruption vote. neighborse is now our in west virginia. she moved from afghanistan. if you read the interview, she tells you why. she is writing a new book about corruption, interviewing people as alexis de tocqueville did. the title? "kleptocracy in america." i interviewed her in this current edition. one of the things she learned from studying corruption overseas is that they often use political correctness to keep the public from rising up agains

at higher multiples these outperform that's why i think they outperformed. >> for biohe can. >> big pharma that's on pig pharma. >> talking about aca overturned either way it's a win for hmos, drug companies if you become more efficient and don't have to cover everybody then you are more efficient and it's a tailwind. if you have to cover everybody you build the business it's a tailwind as well. it's a win/win all around. i like the big pharma as well. >> look at mylan today up very big on the earnings beat and so maybe that shows you how from depressed they are if they can put up decent earnings they have come down a long way. >> well the midterm madness continues on mad money look at the cramer cam there is jim breaking down the midterm playbook and coming up op fast. retail stocks on a tear the last two weeks. traders are betting on big gains in the big names live at the nasdaq in times square much more "fast money" still ahead. there are stores open late for shopping and fun as people seek gifts or even give some. not necessarily wrapped with paper and bows, but gifts of kind deeds, ha

was he hoodwinked by big pharma? >> and for having me and what a difference a couple of months makes back to earlier this year when the president and may launch the blueprint to lower prescription drug prices. refraining from commenting on an individual company i will say this for what you heard in reference to his consistent with the historical patterns and the birds of feather the pharmaceutical industry wants up per year. a very different political environment in which critically important that the president identified even a couple weeks ago dating all the way back to may where the first strategy of the blueprint is to increase market competition and that's where the companies we represent can play a significant role in service to counter labor to the price and brain increases your reference. tranter playtex has had to tell u.s. president in july we are going to cut prices and friday revealed the full 10% of our prescription drugs will see a price hike in january. how do you fight an industry that's unafraid of a

greetings and salutations there's blood in the water park watchers and one of the big dogs a big pharma opioid epidemic has swum way out past the blue eden is desperately trying to swim to shore before the sharks come rolling in and a brilliant bit of good news after a change for a change after a weekend of presidential buffoonery i mean seriously could me at least take a little bit of time to get the name right of the entire town that burned to the ground before launching into his forest floor sweeping routine seriously. anyway like i said in a much needed dose of good news in our feeds it's now being reported that the multi-billionaire sackler family you remember them the predators behind her too far most think that their great philanthropic endeavors can hide their soul tarnishing acts of pushing oxy cotton on the world for fun and. it well they're now facing a mass amount of law of litigation the likes of which we haven't seen since the big tobacco lawsuits in the one nine hundred ninety s. and oh yes they're also facing potential criminal investigations and prosecutions as well leg

big pharma. we've seen good numbers coming biotechs, and ie know we have a number of results over the next couple of days, to big pharma like merck, their pipelines are still extremely strong. not that expensive. give good yields. to do expect healthcare well even if we do get a blue wave. supportive en more in some areas, and trump has views ry clear on his that they are allowed to continue pricing. there are a couple of be looking i would out for, and, in the healthcare sector. california has one that will control the amount that you can charge for dialysis. we need to start looking at the tate by state returns on propositions, too. so much.you gina, intelligence chief equity strategist. it for the closing bell and for me. be t'd you miss?" we'll heading to florida to discuss what the state means for florida. this is bloomberg. florida. this is bloomberg. headquarters in new york. >> here's how we closed the day. mixed. it was a down day for tech. the question is -- "what'd you miss?"? expensiv

so it's time that we talk turkey to our friends at big pharma. and i don't make fun of our friends at big pharma because i use the word friend because we all enjoy a longer life and better quality of life because of miracle drugs. as a fiscal conservative who whole heartedly believes in free enterprise, i don't want the government intruding unnecessarily in the marketplace. the reasons millions of americans benefit from life-saving drugs in the first place is due largely to capitalism and the entrepreneurial spirit that driving innovation -- drives innovation and opens new frontiers of modern medicine. i also believe that strong intellectual property rights help incentivize companies to invest in research and the development so new cures are found for our loved ones. however, the government does have a responsibility to keep a check on unfair business practices and to actually rein in anticompetitive behavior that harm consumers and fleece taxpayers. there's a general agreement that these are constitutional as well as legitimate roles for governm

are going to be aiming at two targets, one, donald trump, the other the pharmaceutical industry, big pharmags chair of oversight committee, tremendous committee and spend about 70% of his time tormenting the trump administration but he says he intends to investigate the pharmaceutical industry and he will issue subpoenas, he will ask questions about drug prices and the goal is going to be kind of use that as cat's paw to get them to compromise on some sort of deal that regulates drug prices in the united states and the problem is that the president of the united states himself seems to be willing to do that, he has talked about associating medicare part 3, prescription prices to those in developed countries over in europe, so big pharma has really got its work cut out for them defending innovation. paul: kate, i think that's a possibility for trump, he might go for that. what about medicare for all, is that something that democrats will push or in the house and senate or are they going to leave that to the presidential candidates? >> you know, paul, i think they are going to be relatively q

. >> don't let big pharma bob be that deciding vote. >> there's a big difference between scott wagner wolf. >>> a lot of campaign money has gone to ads. spending totals $2.9 billion. 52% of that from democrats. most of the rest from republicans. predictions, the biggest headlines wednesday morning. what will they be after tuesday's midterm vote. that's next. be sure to watch "am joy" at 10:00 eastern. she'll be live in ft. lauderdale with the latest on the big races in that state. but first, "saturday night live" takes on white house press secretary sarah huckabee sanders and potential cure for insomnia. >> people are always asking me, how do you sleep at night? they scream it at me all day long. the caravan's headed straight for us and filled with chup a cab rahs and ms-13. >>> i reach for my secret weapon. one little pill eases me into the gentlest of -- >> extra strength quaaludes. michael jackson's doctor told -- here we go. discover. i like your card, but i'm absolutely not paying an annual fee. discover has no annual fees. really? yeah. we just don't believe in them. oh nice. yo

want to do jobs, you want to do these other things, you want to lower prescription drug prices but big pharma has too much influence. to them that we are going to fix that system, make democracy work better, than when we go with these other proposals, they say no you are talking, let's make it happen. that's what we want to make it first. host: a partyline vote with democrats supporting this and republicans against the? guest: coming out of the democratic quarter because a lot of the proposals have let on traditionally. i would love to get bipartisan support for this. actually, when you talk to people out in the country, they support these kinds of democracy reforms across the political spectrum. it's not just democrats, it's not just independents and republicans, one group of them. if everybody who sees this as powerful reforms. in fact, the polling shows that for independents, the number one issue in the last campaign was corruption. they want to see washington work better for them and i think that's how everybody out there feels. let's go do that. let's restore democracy. give it back to i

there is blood in the water park watchers and one of the big dogs a big pharma opioid epidemic has swum way out past the boat is desperately trying to swim to shore before the sharks come rolling in and a brilliant bit of good news after a change for a change after a weekend of presidential buffoonery i mean seriously could me at least take a little bit of time to get the name right of the entire town the.

important as little jemmy's because our salaries are paid for by corporate insurance giants and big pharma see how it all kind of swirls around now let's start watching the hawks. but that's. it's like. if. you. like you know that i got. to. well the water the. top of the. cost of vs boat old row five hundred million trillion dollars of russia's whoever's in power i mean i'm glad you brought up the incident and you know we all know is where this. obama didn't put up with his nonsense either the difference is obama just tended to lead keep his calm and cool while you know jim acosta did he did which is a little bit grandstanding it always feels a bit like he's auditioning for is talk his own talk show which is great because somebody just. sort of to see of what we need in that job you need a reporter and what he did in my opinion was pushing mulayam of being going from an opinion person or an analyst to a reporter also you're not not to were there to do a job as a white house or porter and there were other reporters who are african-american woman are called a racist by donald trump did she

enthusiastic traders and company executives in firms from financial services to infrastructure to big pharma and the internet giants we'll all be watching anxiously to see how the new landscape will impact their companies what will it mean for their bottom lines and what about trade with the rest of the world let's take a look at what's the new congress might or might not be able to accomplish with conservative commentator steve malzberg hey steve thank you for looking at this i know you were up late last night watching the results and we appreciated that i enjoyed watching you but let me ask you nancy.

important as little germany because our salaries are paid for by corporate insurance giants and big pharma so you know all kind of swirls around well let's start watching the whole. thing. with the. real thing it's like. at the bottom. like you that i got. with. the. welcome or the watching dogs i am tired rover the girl and tell her the. cost of verses battleground five hundred million trillion and whatever the worse is there ever is in power i mean i'm glad you brought up that saying instead and you know we all know is where this. obama didn't put up with his nonsense either the difference is obama just tended to lead keep it calm and cool while you know jim acosta did he did which is a little bit grandstanding it always feels a bit like he's auditioning for his to his own talk show which is great because somebody just get one would have to say about what we need in that job you need a reporter and what he did in my opinion was pushing mulayam of being going from an opinion person or an analyst to a reporter also you're not not of us are there to do a job as a white house or porter and t

as important as little jimmy because our salaries are paid for by corporate insurance giants and big pharma so you know all kind of swirls around that let's start watching the whole. thing. with the. real thing it's like. the bottom. like you that i got. with. this. well remember the watching the entire rover the door and tell her the. cost of versus battleground five hundred million trillion and whatever the worse is there ever is in power i mean i'm glad you brought up today and you know we all know is where this. obama didn't put up with his nonsense either the difference is obama just tended to lead keep it calm and cool while you know jim acosta did he did which is a little bit grandstanding it always feels a bit like he's auditioning for his to his own talk show which is great because i mean just give me one would have to say about what we need in that job you need a reporter and what he did in my opinion was pushing mulayam of being going from an opinion person or an analyst to a reporter also you're not mad to vest we're there to do a job as a white house or porter and there were. t

want to do jobs, you want to do these other things, you want to lower prescription drug prices but big pharma has too much influence. to them that we are going to fix that system, make democracy work better, than when we go with these other proposals, they say no you are talking, let's make it happen. that's what we want to make it first. host: a partyline vote with democrats supporting this and republicans against the? guest: coming out of the democratic quarter because a lot of the proposals have let on traditionally. i would love to get bipartisan support for this. actually, when you talk to people out in the country, they support these kinds of democracy reforms across the political spectrum. it's not just democrats, it's not just independents and republicans, one group of them. if everybody who sees this as powerful reforms. in fact, the polling shows that for independents, the number one issue in the last campaign was corruption. they want to see washington work better for them and i think that's how everybody out there feels. let's go do that. let's restore democracy. give it back to i

kim: also with big pharma taking a look at them. >> tell us something we don't know about you we have not heard on the campaignow trail. [laughter] kim:. >> this could be fun. . >> in college i was a victim of a campus sexual assault but i was a fine arts major graduating from vermont college completely random but in fact, i have an art studio in my condo. [laughter] scanlon: i would tell you about the chickens but they were in the video. [laughter] i wanna disco dance contest when we were 20 but that's been in the video also. [laughter] and went to drive an outboard boat when i was six years old. [laughter] . >> you two are lawyers right? [laughter] thank you both for humoring us. beer at that point of the statements closing two minutes each we will begin with you. >> with the league of women voters and the naacp if you have any questions please go to scanlon for congress also look up your voter registration but the deadline is october 30th looking at campaign funds the other night i cannot show it literally but it was a picture of my husband and i going to the polling place and that

but in the long run, the agreement trump made with canada would benefit big pharma in the midwest. me isr thing that bothers you get politicians that leave office and once they leave office, they go to work for lobbyist groups. there should be a mechanism put in where if you are a representative, i do not care if you are a senator or in the house of representatives, you should never be allowed to lobby the government. they know all the ins and outs. that is where the money goes. they don't care about the american people. let me start with trade. that is nafta. parts jobs, they moved overseas, i think that would have happened whether or not we had nafta. the companies could have basically in getting the same thing for less overseas. americans everywhere paid less for cars. nafta was good for farmers in your friend was right. i think the new agreement will begin for farmers and may help manufacturing. host: under the democratically controlled house, is that in limbo? only playing politics and not wanting president trump to get any victory. it was negotiated by an old , navarro, and i

siesta traitors and company executives than firms from financial services to infrastructure to big pharma and the internet giants will all be watching anxiously to see how the new landscape will impact their companies what will it mean for their bottom lines and what about trade with the rest of the world let's take a look at what's the new congress might or might not be able to accomplish with conservative commentator steve malzberg hey steve thank you for looking at this i know you were up late last night watching the results and we appreciated that i enjoyed watching you but let me ask you nancy pelosi tweeted the current minority leader and potential speaker of the house in the next car and she said it deserved to be voted as a speaker once again when they they offered that president trump said she deserved to be sworn in as speaker of the house and he may be doing that tongue in cheek but can you see the two of these folks working together. i could see it under the correct circumstances by the way of trump perked up later in the press conference believe me but i could see it under th

this is a hot area for all of the big pharma companies at the moment.ore as a takeover target. scarlet: i know you don't cover tesoro typically from a stock perspective, but it is a classic company, not profitable, perhaps really just trading on future growth prospects or the pipeline of drugs. what do we know about the company, maybe there pipeline, that makes them so valuable to a big suitor? they have a great drug in prospects. you could see that reflected a year ago in the share price they were trading on. the shares are well down. the reason they have called off so much is they have seen other people come into their market. they have also developed a company called clovis, which is up on the back of this news. had not great data in the last few weeks. are there other drugs in the pipeline? theseke all of development stage companies, they have one drug that is potentially the blockbuster. we have seen it a lot with these kind of deals, where the big pharma companies will pay for the risk of a small chance this thing comes off, but if it does, it cou

that will be good for hospitals so big pharma is in the cross hairs but hospitals are potential winnerscy pelosi said she wants to pursue potential infrastructure deal with president trump but i think that will be tough because of rising deficits and resistance from republicans in the senate from making them bigger >> one of the big questions i've got is how are they going to translate these economic anxieties we're seeing people reflecting in the exit polls you've talked about the economy not being top of the list but health care right at the top of the list, that's about worry about what will happen to me and my family. and immigration, worry about what will happen to the job market when you have an era of divided government and you have the house and senate going in two total different directions, is there any way legislatively for democrats and republicans to solve these issues that americans are saying we're so anxious about? >> possible but not likely you have unexpected moments where both the white house and congressional leadership may feel an imperative to do something and that

i also agree with what is happening in law enforcement to make sure we are going after big pharma and in terms of prosecuting traffickers should continue. >> tell us something we don't know about you that we haven't heard on the campaign trail. as i've mentioned in college i was the victim of a campus sexual assault but actually, i was a fine arts major and i graduated at vermont college and a completely random fact i have an art studio. >> i would tell yo you i found a disco dance contest at age 20 but we had a disco video, too. i learned to drive when i was 6-years-old. [laughter] the >> and you are lawyers write? >> thank you both for humoring us. we are at that point o the poine program for closing statements. they are two minutes each and is agreed upon, we will begin with you. >> i want to thank the league of women voters. an hour isn't that long since if you have questions about my position or background, please go to the site and look things up and you can find your polling place, look up your voter registration and get an absentee ballot the deadline is the 30th. we were look

this could see a pop because donald trump has been threatening big pharma with price controls on medicationsidlock, the democrats coming in, this could be a boon for these sectors. if they sweep congress, that is an interesting story. then there could be a fear trade because the dems could push their medicare system system which means lower drug prices. let's take a look at some of the stocks that could be impacted. amgen, i'll agenda. they could be impacted. up ton see while amgen is more than 7%. you can see there has been a fall. about 5%.down by another sector we should look at is the bank stocks. take a look at my second chart. since see a trump bump the election. the index has been outperforming the s&p 500 until earlier this year. it actually is now below the s&p 500. they say they are positive. it seems because trump's regulators, he is going to be putting proposals in. even if the house does go democrat, the senate is expected to be republican and they will kill anything the house tries to pass. >> thank you. the newhaidi at economy forum. haidi? >> thank you. speech,introductory mi

. >> big healthcare, big hospital entities, big pharma they all play a role in our healthcare and want: they see the big pile of money. >> providers tends to charge more. that is a big problem. it is cost, debt and allocation of resources. rob: the popularity of obamacare has skyrocketed recently. it is down in the 30% range a few years ago, now it is close to 60%. it is very popular. i can't help but think the reason why is republicans talked all the stress all those years and had no solid replacement for this plan and if they lose next tuesday a lot of it will be on the republican party. >> i agree with you. the crucial aspect they failed to emphasize, no republican wants to eliminate coverage for preexisting conditions. everything we have ever done is meant to help people with preexisting conditions. rob: not according to democrats. >> democrats are propagandizing that. what obamacare did was a $1 trillion gift to the bureaucracy and insurers at premium payer and taxpayer expense and one of the reasons obamacare isn't as unpopular is the trump administration has done things to help

but lately a number of big pharma names have been annihilat annihilated, which is highly unusual.n't these great companies it's a good time to talk about the unkars richaracteristic beh. the stocks are selling like donna summer, because when they're bad, they're so, so bad. all allergen, when they caught a takeover bid from pfizer, i decided not to ring the register and i rode it down 50% before dumping my position. i didn't like the company was losing exclusivity after my trust look a loss, what happened the stock rallied furiously. but this week, the stock came plunging back to earth until today. what happened? they reported a quarter that on the surface looked impressive. while almost every analyst in the quarter, we started hearing talks the ceo wasn't bringing out enough value quickly enough and the stocks got obliterated if you bought them when it was dumping up, it lost 20 points in the blink of an eye. they do have two huge drugs in the pipeline, for migraines and treatment for depression but their competitors at amgen has a new migraine drug that has a new drug that is no

i have not found it yet there is too many issues with big pharma and medicine and victims and families try to get my head around it and i haven't been able to do that yet. i hope i do and i can work out that story. that's the way i'm always thinking about the headlines of the magazine articles once i get an idea it will rattle around and then the good one stick i am always collecting research newspaper articles and stuff online and the files are thick. once i have a really good idea then how would you tell the story? and then that's a process i will say chapter one what happens? i ride a paragraph when i get to chapter 40 i better we finished or i'm in trouble. that is the organization what you don't want to do is what you need to do number one is outline number two is revise never to do in the first or second draft. >> that weeds out a lot of things that our unnecessary i can stand it when my wife says this is really dragging right here. this is too slow. that's an insult. ifixit. . >> i am still moderating by the way many books turned into movies once you find out one has been select

big pharma has shied away from it, focusing on other areas.petitor with johnson & johnson, but what is interesting is that it is behind where we are. >> it makes sense for them to potentially buy corbus? yuval: that is a provocative idea. it makes sense for big pharma to look at the companies that have built up expertise in biology in conducting clinical studies. >> let's look at cannabis discussion, partially why we are here and why there is a much focus on the stock. if you look over the last six months, there is correlation. what you don't actually have anything from the plant in your drugs. is this the market misunderstanding what corbus does? yuval: i'm not entirely sure about that. the one thing we have in common is that the synthetic and the body'srived target the system. the plant-derived ones target brain activity. at corbus, our focus is outside the brain. it is on the main system. >> a lot of times we sit down and cannabis many ceo's they talk about it as being a panacea that will solve all kinds of different maladies. how farther c

leadership from big, high quality growthy companies, tech on one hand and big tech in particular, big pharma a lesser extent consumer staples the two big engines, health care and technology move forward i think getting past the corrective period. >> and as we get to midterms and parse results tomorrow and days that follow, how much of a risk do you think the fed poses to growth going into the december hike we think? >> i don't really think it does. i've always been of the view that what's really important is the growth of the global quantity of money and that's driven by the shape of the global yield curve while our yield curve has gotten a little flatter, it is adequately steep and the non-u.s. gdp weighted curve has gotten a little steeper. and in today's world and you intuitively know this, big banks can move money country to country at the push of a button faster than we can think about it, so the money flows on a global basis, not on a u.s. only basis. and i don't think the fed individually has as much power as it thinks it has or most people think it has, because we really live in this

. >> so the big opportunity there, what other markets besides china would you say the big pharma giants looking to for growth >> i think they're looking at all of southeast asia. countries like vietnam which is growing fast looking at any of those parts of the world. south america, because of the currency issues has been ho-hum. that may recover parts of that are a good market. you see that with the drugs that some biotechnology companies have developed they've done well in places like south america. africa is a long way behind. >> if we're thinking about the european drugmakers compared to the u.s., which offers more of an upside in terms of valuation from here? >> focus on the companies that are developing drugs with value. in our view, novartis, astrazeneca. i think keep an eye on roche i think roche has a great pipeline, but they have this bisimilar headwinds. copies of their drugs could be coming to market but they are innovative. keep that in mind for the future >> daniel, thank you very much for coming in. thanks also to julianna for that interview. >>> sticking with specific com

that means big pharma and big fossil fuels, unquote. chase and ojeda in west virginia are pointing the way toward a law and order rhetoric that could lead to a populist challenge to the corporate criminal status quo and the market fundamentalism that underpins the ruling cleptocarcy. may this forum serve as a launching pad for a law and order movement to combat market fundamentalism and the corporate crime and violence it has unleashed. thank you. >> thank you very much, russell. in our continual quest for liberating reality, in place of controlling mythologies, our next speaker is robert weissman, who, when he was an undergraduate at harvard, sponsored studies, showing how much control corporations had over harvard university. and i remember in a particular event there, he impressed me so much that i said, well, i think he is going to be a future civic leader nationally. and so he has become. when he was working with us, he was working with jamie love on bringing big pharma to accountability, because at that time, they were charging $1

when you look at nafta 2.0, we're looking at how big pharma played a big role. i was in mexico is a couple of weeks ago and he went to a pharmacy and asked how much is like in most expensive, we have an infection, what do you take? antibiotics, thank you for your most expensive antibiotics. and they said 250 250 pesos. i said, $12? yes. that's what it is. i pay $250 for antibiotics after insurance for my children. and that's going away because of nafta 2.0. you will no longer be of the cost in new mexico for cheap antibiotics. anyway, we talked a lot about, not a lot of press but we talked some about policy. one of the things that your book touches on is how these problems are not unique to white working americans. and that in some way we had to understand that we have done nothing wrong. we went to school. we paid our bills. we believe in the american way. then what is the problem and how come it exacerbates more when were speaking about people of color? and both of you talk about this in your books? >> i have to be aware that when i was writing my book because

president trump has simply called out big pharma and said these guys are getting away with murder. that almost seems like a page certainly in the past out of democrats' books. he's made it his own. what do you think of any kind of ability there, and do you make a move the day after these elections? >> so do i make a move the day after, no. because i think that's when, you know, the market psychology really sets in. i think you have to let things digest a little bit. you just made a great point, liz. the drug stocks, that whole pharma sector, that is another area to really look hard into, just like phil said, about infrastructure. i totally agree with that. that being said, i think whatever the outcome is tonight, whatever the outcome is tonight, once everything is digested, it is a buy going forward to the end of the year and into the first quarter. just like you talked about earlier with the rain, the sleet and everything, there's a blizzard couldn't keep people away from the polls today. that's how anxious people are to get out there. liz: i don't know about you guys, i absolutel

big pharma who i hate and loathe, there are many things about this i think they should be condemned and sued for. if they had never existed, there was still have been this epidemic. it would have taken a different form, and it would have been less harmful. i am not dismissing the real harm. you mentioned the crack epidemic. we know now looking back it was too simplistic. where did it happen? places distressed and traumatized. we look back-- we should tell people to just say no, punish the evil, evil drug dealers. we know it was a manifestation of distress, people needed help. it is too simplistic to focus on the chemical. we have to look at why people are turning to the chemical. one last point, look at where it is happening. people on the faculty of harvard have much better access to opiate-based painkillers that people in rural kentucky or, new hampshire. why is there little of the addiction in the faculty of harvard and so much in west virginia? because their lives are harder and worse and in more pain. we have got to deal with these people. [speaking simultaneously] >> it needs to b

we should also mention there's another health care sect orthat's popping on midterm results, big pharma. high drug prices are one of the few bipartisan issues. the new split congress would likely agree. democrats say drug prices will be a top priority but all these names are up. biogen, bristol-myers squibb. so what is the best vehicle for your investments and portfolios to get over the humps and bumps that might be along the road? to the floor traders. john, with a split decision, where are you seeing the best opportunities for investors' money, people who are watching right now, ready to pull the lever on their account? >> i think it's just the overall market from a macro sense. we have had this date on the calendar and i think it really put a hold on what investors wanted to do, not knowing how this was going to turn out. as you said, now that we know the landscape moving forward, whether or not you agree with it or how you voted, just knowing what things are going to look like for the next couple years is very, very important. we talk about bumps down the road. this market is not go

why would big pharma lead the market up? >> sometimes investing is like working for the mob.any questions. okay? we don't know why. this is the nature of markets. they move in trends, trends that tend to unfold over a long period of time and throughout this entire year, all the fang stocks and trade tariffs, et cetera, big cap pharma, names you know like pfizer, like merck, all doing consistently well. many times breaking out to multi-month or even multi-year highs. this is a bullish sign. we don't know exactly what the reason is. maybe it is more regulation in health care, maybe it's less regulation in health care, maybe it's some of the older baby boomers needing more health care. for whatever reason, this is a strong group and essentially investing is like betting on racehorses. you want to go with the winners. stuart: so the capitalist pig guy doesn't know why something is going up, he only knows that it's going up, and therefore, he's going to buy it. is investing that simple? >> i will just give you a historical example. the bull market in gold. from 2001 to 2012, gold

>> i think the corporations who got that giveaway, big pharma companies, they got $40 billion in tax giveaway. they did not need that. the middle class needs that. they are the ones who are driving our local economies. they are the ones who need more. and they needed more permanently. next question is for you congressman davis. rep. davis: the families i speak to, they like this tax cut. they liked the fact they have an average of $2000 more in their budget. we have chosen growth. my opponent wants to talk about a tax plan taking away social security and medicare. seniors, if you are watching, do not believe the lies. we are trying to protect social security and medicare. we are trying to make sure it continued to be there, not just for you and the next generation, but we want to make sure these valuable programs are there for your grandchildren. right now, it is people like my opponent who have no plans that are going to see those programs be insolvent as early as 2026. that is not what i went to washington to do. i went to washington to protect them and protect economic opportunity

lemonis: because pot is still illegal under federal law, big pharma, tobacco, and other giants -- they'ree sidelines... for now. adam: you don't have many people competing. it's the most inefficient market of our lifetime. lemonis: because people see the risk of the federal government not really allowing it, and wondering if they're going to flip flop. adam: i welcome the perception of that risk because it allows me to run as far and as fast as i can. lemonis: i thought adam was a very smart guy, very sophisticated. he understands his business. i would've never imagined that the retailing of marijuana would ever be this slick, this well-merchandised, and this lucrative. prior to going into the store, i would've never contemplated investing in this concept. but after seeing the frozen goods, the beverages, the consumerables, this is a real business -- a real business with a real retail footprint. you may not like it morally, but you definitely have to pay attention to it. up next, chasing their dream one edible at a time. if this doesn't work, you've lost the money and you have no income.

big pharma who i hate and loathe and i agree, there are many things about this, i think they should be condemned and sued for. if they had never existed there would still have been this epidemic of despair and it would have taken a different form and that would be less harmful to people. i'm not dismissing the real harm from these drugs. there is. but we have to understand, you mentioned the crack epidemic. so-called crack epidemic. we know now looking back that it was too simplistic. when did that happen? it happened in places most distressed and traumatized. when we look back, we are way too simplistic to do the nancy reagan, tell people to just say no, punish the evil drug dealers. we now know it was a manifestation of distress. people needed help. it's too simplistic to focus just on the chemical. we have to look at why people are pining for this chemical. one last point on this. we have to look at where it's happening. people on the faculty of harvard have much better access to opiate based painkillers than people in rural kentucky or new hampshire or the places -- why is there ve

host: on twitter, we have to regulate big pharma, it is not justing yours -- cures, drug dependency.imothy is calling from harpers mill, in new york. good morning, timothy. caller: we do not get the treatment -- we do not get the treatment we need to get the cure of disease is we need. host: what is needed specifically that is not there? caller: i have gone to doctors and they said medicaid would not and i have treatment saidto dentist and dentist they will not do what i need done. host: anything else, timothy? caller: yes, i feel it is ridiculous that we are giving andcaid to illegal aliens stuff like that. all that money going to illegal aliens, not to citizens. host: on the line from hackettstown, good morning. caller: thank you for taking my call. i really like c-span. perhaps everybody would be happy if the average american was eligible for the same benefits and plan as congress has. there would be no argument on either side. i am sure congress would never say they deserve a better plan than the average american. i also feel that -- has anyone ever really done a study about all

now, the big pharmaceuticals, big pharma, the big insurance companies, not the little ones, the big one the pharmaceuticals that signed on to support obamacare, they could tell and i could tell from reading the bill they were going to make billions and billions more than they've ever made in their history. but as i told some of the lobbyist you guys signed your own death warrant, yeah, you're going to make billions and billions more, maybe 15 years. but then eventually you're going to be capped. and you're going -- not going to be able to collect for research and development. you're going to be unable to stop creating life-save, life-enhancing medications and you're going to be like a third world pharmaceutical. they didn't care. because these guys had golden parachutes. they knew they'd make billions more because of what obama did for them and they did. and they have. and they still are yes, we've lost a lot of insurance companies, big companies are doing great. they're doing real well. in fact, i was shocked -- i missed it when i read the bill but these biggest insurance companies cou